1 April 2024 false No description of principal activity Taxfiler 2024.6 10978317 business:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 10978317 2024-03-31 10978317 2024-04-01 2025-03-31 10978317 business:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 10978317 business:FilletedAccounts 2024-04-01 2025-03-31 10978317 2025-03-31 10978317 business:Director1 2024-04-01 2025-03-31 10978317 business:Director2 2024-04-01 2025-03-31 10978317 business:RegisteredOffice 2024-04-01 2025-03-31 10978317 2024-03-31 10978317 core:WithinOneYear 2025-03-31 10978317 core:WithinOneYear 2024-03-31 10978317 core:ShareCapital core:PreviouslyStatedAmount 2025-03-31 10978317 core:ShareCapital core:PreviouslyStatedAmount 2024-03-31 10978317 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2025-03-31 10978317 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2024-03-31 10978317 core:PreviouslyStatedAmount 2025-03-31 10978317 core:PreviouslyStatedAmount 2024-03-31 10978317 business:SmallEntities 2024-04-01 2025-03-31 10978317 countries:EnglandWales 2024-04-01 2025-03-31 10978317 core:PlantMachinery 2024-04-01 2025-03-31 10978317 core:FurnitureFittings 2024-04-01 2025-03-31 10978317 core:ComputerEquipment 2024-04-01 2025-03-31 10978317 core:PlantMachinery 2024-03-31 10978317 core:FurnitureFittings 2024-03-31 10978317 core:ComputerEquipment 2024-03-31 10978317 core:PlantMachinery 2025-03-31 10978317 core:FurnitureFittings 2025-03-31 10978317 core:ComputerEquipment 2025-03-31 10978317 business:Director1 1 2024-04-01 2025-03-31 10978317 business:Director1 1 2024-03-31 10978317 business:Director1 1 2025-03-31 10978317 2023-04-01 2024-03-31 iso4217:GBP xbrli:pure
Company Registration No. 10978317 (England and Wales)
Augment Healthcare Limited Unaudited accounts for the year ended 31 March 2025
Augment Healthcare Limited Unaudited accounts Contents
Page
Company information
3
Statement of financial position
4
Notes to the accounts
5
- 2 -
Augment Healthcare Limited Company Information for the year ended 31 March 2025
Directors
Mr DV Marmion Mrs N Marmion
Company Number
10978317 (England and Wales)
Registered Office
Orchard House Wyatts Lane Horsted Keynes RH17 7AH
- 3 -
Augment Healthcare Limited Statement of financial position as at 31 March 2025
2025
2024
Notes
£
£
Fixed assets
Tangible assets
4
4,913
889
Current assets
Debtors
5
2,796
229,981
Cash at bank and in hand
222,104
27,044
224,900
257,025
Creditors: amounts falling due within one year
6
(78,697)
(74,615)
Net current assets
146,203
182,410
Net assets
151,116
183,299
Capital and reserves
Called up share capital
100
100
Profit and loss account
151,016
183,199
Shareholders' funds
151,116
183,299
For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 16 October 2025 and were signed on its behalf by
Mr DV Marmion Director Company Registration No. 10978317
- 4 -
Augment Healthcare Limited Notes to the Accounts for the year ended 31 March 2025
1
Statutory information
Augment Healthcare Limited is a private company, limited by shares, registered in England and Wales, registration number 10978317. The registered office is Orchard House , Wyatts Lane, Horsted Keynes, RH17 7AH.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Plant & machinery
25% straight line
Fixtures & fittings
25% straight line
Computer equipment
33% straight line
4
Tangible fixed assets
Plant & machinery
Fixtures & fittings
Computer equipment
Total
£
£
£
£
Cost or valuation
At cost
At cost
At cost
At 1 April 2024
1,775
298
4,394
6,467
Additions
5,958
-
-
5,958
At 31 March 2025
7,733
298
4,394
12,425
Depreciation
At 1 April 2024
886
298
4,394
5,578
Charge for the year
1,934
-
-
1,934
At 31 March 2025
2,820
298
4,394
7,512
Net book value
At 31 March 2025
4,913
-
-
4,913
At 31 March 2024
889
-
-
889
- 5 -
Augment Healthcare Limited Notes to the Accounts for the year ended 31 March 2025
5
Debtors
2025
2024
£
£
Amounts falling due within one year
VAT
2,796
2,586
Trade debtors
-
226,935
Other debtors
-
460
2,796
229,981
6
Creditors: amounts falling due within one year
2025
2024
£
£
Trade creditors
1,762
11,756
Taxes and social security
21,874
46,014
Other creditors
4,809
-
Loans from directors
48,252
14,818
Accruals
2,000
2,027
78,697
74,615
7
Loans to directors
Brought Forward
Advance/ credit
Repaid
Carried Forward
£
£
£
£
Loans from directors
(14,818)
(33,434)
-
(48,252)
(14,818)
(33,434)
-
(48,252)
8
Average number of employees
During the year the average number of employees was 2 (2024: 2).
- 6 -